Scribe Therapeutics Inc. SCTX · SEC Filings

website

Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-b...

Price16.68

Market Cap269.92 M

Float1.7 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Sep 2, 2026

News

TYPE

HEADLINE

FILED AT

8-K

Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates

Sep 2, 2026

8-K

Scribe Therapeutics Inc. Completes Initial Public Offering and Adopts Amended Governance Documents

Jul 27, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Jul 24, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 24, 2026

FWP

OFFERING - IPO | Bank: Leerink Partners, Goldman Sachs & Co. LLC, Guggenheim Securities, Wells Fargo Securities

Jul 23, 2026

S-1MEF

OFFERING

Jul 23, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Jul 20, 2026

S-1/A

OFFERING - IPO | Bank: Leerink Partners, Goldman Sachs & Co. LLC, Guggenheim Securities, Wells Fargo Securities

Jul 20, 2026

S-1/A

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Jul 10, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

RA CAPITAL MANAGEMENT, L.P. (Filed by)

Aug 3, 2026

SCHEDULE 13D

Avoro Capital Advisors LLC (Filed by)

Jul 30, 2026

SCHEDULE 13D

ELI LILLY & Co (Filed by)

Jul 30, 2026

Andreessen Marc L (Reporting)

Jul 29, 2026

GORDON CARL L (Reporting)

Jul 29, 2026

ORBIMED ADVISORS LLC (Reporting)

Jul 29, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 24, 2026